Welcome to the RAND Drug Policy Research Center
Providing decisionmakers with rigorous, nonpartisan research on substance use and drug policy
Since 1989, the RAND Drug Policy Research Center has conducted research to help decisionmakers in the United States and throughout the world address issues involving alcohol and other drugs. In doing so, the Center brings an objective and data-driven perspective to this often emotional and fractious policy arena.
RAND DPRC Research Making an Impact
Evolution of the U.S. Overdose Crisis
Bryce Pardo testified before the House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations on the role of synthetic opioids in the U.S. overdose crisis.
Funding to Address the Opioid Epidemic
Rosalie Pacula testified before the House Appropriations Committee about the evidence and effectiveness of different drug policy strategies for addressing the opioid epidemic.
L.A. Holds Hearing on Proposed Cannabis Advertising Restrictions
Citing research by Liz D'Amico and a host of other RAND researchers, the City of Los Angeles is proposing an ordinance that recommends restricting cannabis advertising near schools and other "sensitive locations," including alcoholism or drug abuse recovery or treatment facilities, public libraries, public parks, schools, and residentially zoned property.
Cannabis Legislation in Canada
Beau Kilmer provided testimony to the Canadian legislature on different alternatives to prohibition, including considerations for prices, taxes, and international implications.
Medical Marijuana Policy in Florida
Rosalie Pacula testified before the Florida House of Representatives Health & Human Services Committee on medical marijuana regulation, including topics of supply structure, commercialization, and potential impact on youth.